AzTrials
AzTrials

Brain InjuriesNCT04730167

The Monaco Initiative for Concussion in Motorsport Pilots

An observational study of Brain Injuries and Concussion, Brain, run by Association de Recherche Bibliographique pour les Neurosciences at 1 site in Monaco.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims: to observe a population particularly exposed by the past to brain trauma and concussion: Motorsport Pilots who are retired from a professional practice of motor sport; to report results of their neuro-cognitive evaluations, to determine if specific profiles emerge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Brain Injuries, Concussion, Brain, Sport Injury
What is being tested?
Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.
How many people
12 participants
Where
1 siteMonaco
Study dates
5 Oct 2021to 31 Aug 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Retired motorsport pilots coming to the CHPG for a memory assessment or concussion assessment, meeting the study's inclusion criteria, and volunteering to participate. All assessments and examinations are carried out in routine care, so study essential data will be collected from the patient's medical file (source file): Demographic data, Medical history, Sport practice History of sports, Results of neurological and neuropsychological assessments, Eye-tracking results, MRI results, PET-FDG results.

  • Men or women.
  • Aged 18 years and older.
  • Retired motor sport pilot (Formula 1 or rally).
  • Expressing a cognitive, memory, somatic, emotional complaint, sleep disorders or a concern following the practice of Motorsport, that motivate carrying out of a memory assessment or a concussion assessment in routine care.
  • Who are willing to participate in the study and give their written informed consent.
  • Covered by a health insurance system.

Trial locations and contacts

1 site in 1 country.

Monaco1 site
  • Princess Grace Hospital / Department of Nuclear Medicine / Memory Center of the Rainier III Clinical Gerontology Center

    Monaco, 98000

Other trials in Monaco

About this study

Official title: The Monaco Initiative for Concussion in Motorsport Pilots: Brain Exploration in Retired Motorsport Pilots

The study aims:

  • to observe a population particularly exposed by the past to brain trauma and concussion: Motorsport Pilots who are retired from a professional practice of motor sport;
  • to report results of their neuro-cognitive evaluations,
  • to determine if specific profiles emerge.
  • to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.
  • to evaluate the contribution of the various examinations performed as part of a concussion assessment in routine care (eye-tracking, brain imaging, Neuropsychological Assessment).
Read the detailed description

The Memory Center of the Rainier III Center and The Department of Nuclear Medicine of the Princess Grace Hospital are particularly aware of evaluation, management and monitoring of patients who have suffered brain trauma, or concussions, and the study of possible long-term consequences.

They regularly receive patients, referred by neurologists or spontaneously coming for consultation, for whom the carrying out of a complete in-depth evaluation is recommended, because of their medical history and their personal history.

In partnership with the "Fédération Internationale de l'Automobile" (FIA) and the "Automobile Club of Monaco" (ACM), the Princess Grace Hospital team hopes ultimately to set up a screening campaign for traumatic brain injuries among a particularly exposed population: motorsports people.

In this context, inspired by the work carried out by the Cambridge University team (the Rescue Racer Study) and the FIA recommendations, the Sponsor wishes to carry out an observational study with retired motor sportspeople.

The objectives are to study a population particularly exposed by the past to brain trauma and concussion (who is retired from a professional practice of motor sport), to report results of their neuro-cognitive evaluations, and to determine if specific profiles emerge, to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.

Being tested
Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.
Keywords
Motorsport Pilots, Concussions, Brain trauma, Traumatic brain injuries, MRI, positron emission tomography (PET) scan, Video-oculography, Oculomotor behaviors
Medical subject headings
Brain Injuries, Brain Concussion, Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.Other

    Essential data for this study are those collected during the concussion assessment, carried out as part of routine care at Princess Grace Hospital (medical background; history of sports practice and history of concussions; data extracted from clinical and neuropsychological evaluations, from imaging exams (MRI and PET-Scan) and from eye-tracking evaluation).

Study groups in NCT04730167
Study groupRoleWhat they receive
Retired Motorsport PilotsConcussion assessment
Receives: Other: Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patients description

    Describe the profile of included patients

    Measured: Baseline

  2. Medical history of concussion

    Describe the Medical history of concussion of included patients

    Measured: Baseline

  3. Presence of Post Concussive Symptoms

    Assessed by the Symptoms Scale of the Sport Concussion Assessment Tool (SCAT), composed of 22 post concussive symptom items graded on a scale from 0 (no symptoms) to 6 (severe symptoms), summed to form a symptom severity score (range 0-132).

    Measured: Baseline

  4. Neurological evaluation

    Assessed by the Neurological exam part of the Sport Concussion Assessment Tool (SCAT), composed of 5 questions.

    Measured: Baseline

  5. Postural stability

    Assessed by Balance Error Scoring System (BESS). Score of 0-60 (lower scores indicate better balance and less errors)

    Measured: Baseline

  6. MRI scan

    MRI data are described according to their nature (lesion / atrophy / sequel / signal anomaly), and classified as present or absent.

    Measured: Baseline

  7. PET/CT scan - Visual analysis

    Description of possible hypometabolic or hypermetabolic areas of the cerebral cortex on the PET / CT images of the subject.

    Measured: Baseline

  8. PET/CT scan - Parametric analysis

    The uptake values of [18F]-2-fluoro-2-deoxy-D-glucose (18-FDG) (average uptake and standard deviation) of several target regions of the subject's cerebral cortex will be entered in comparison with an age-matched database developed in the Scenium software from Siemens Medical Solutions USA® (software version VB30A)

    Measured: Baseline

  9. PET/CT scan - other description

    Description of any abnormalities found on non-opacified CT slices.

    Measured: Baseline

  10. Global cognitive performance

    MONTREAL COGNITIVE ASSESSMENT (MOCA) is used to evaluate Global cognitive performance. MOCA is a 30-question general cognitive function assessment. The maximum score is 30. Performance of each participant is compared to their reference sample (depending on age, sex and level study).

    Measured: Baseline

  11. Episodic memory performance

    The Grober and Buschke Free and Cued recall (16 items) or the Selective Reminding Test are used to evaluate Episodic memory. Performances of each participant are compared to their reference sample (depending on age, sex and level study).

    Measured: Baseline

  12. Executive performance - Trail Making Test A&B

    Trail Making Test (T.M.T) A\&B is used to evaluate executive performance. The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper, in the shortest time possible without lifting the pen from the paper. Time performances of each participant are compared to their reference sample.

    Measured: Baseline

  13. Executive performance - Stroop test

    Stroop test (GREFFEX) is used to evaluate executive performance and more specifically inhibition. The time to complete each condition (in seconds) is recorded, as well as the number of uncorrected and corrected errors. Stroop task performances of each participant are compared to their reference sample.

    Measured: Baseline

  14. Executive performance - B.R.E.F.

    The "Batterie rapide d'évaluation frontale" (B.R.E.F.), or Frontal Assessment Battery at Bedside (F.A.B.), is used to determine the presence or not of a cognitive and behavioral dysexecution syndrom. The maximum score is 18. Performances of each participant are compared to their reference sample.

    Measured: Baseline

  15. Executive performance - The Modified Card Sorting Test of Nelson (MCST)

    The Modified Card Sorting Test of Nelson (MCST) is used to evaluate executive function in patients with focal, traumatic and degenerative brain diseases. Performance on the MCST is scored by computing the number of categories achieved by a participant, and the number of perseverative errors. Performance of each participant are compared to their reference sample.

    Measured: Baseline

  16. Verbal fluency

    Verbal fluency test is a short test of verbal functioning. It consists of two tasks: category fluency and letter fluency. Participant is given 1 minute to produce as many unique words as possible within a semantic category (category fluency) or starting with a given letter (letter fluency). The participant's score in each task is the number of unique correct words. Performances of each participant are compared to their reference sample.

    Measured: Baseline

  17. Visuospatial/constructional ability

    Rey-complex copy figure test is used to evaluate visuospatial/constructional abilities. Performance of each participant is compared to their reference sample.

    Measured: Baseline

  18. Social cognition and Emotional assessment

    The Mini-sea is used to evaluate Social cognition. Evaluation criteria: Scores to Ekman Faces task (1976): total score / 35 and sub-scores / 5. Performances of each participant are compared to their reference sample.

    Measured: Baseline

  19. Selective and sustained attention

    The d2 Test of Attention is a cancellation test of attention and concentration that measures selective and sustained attention. Participant cross out any letter "d" with two marks around above it or below it in any order. The surrounding distractors are usually similar to the target stimulus, for example a "p" with two marks or a "d" with one or three marks (Ability to concentrate, Processing speed, Percentage of errors). The quotation provides values for the three main indices. Performances of each participant are compared to their reference sample.

    Measured: Baseline

  20. Storage and handling of information, short term and working memory skill

    The Digit span and spatial span tasks (Empans) assess the storage and handling of information, short term and working memory skill. Participant reads a sequence of numbers and is asked to repeat the same sequence back to the examiner in order (forward span) or in reverse order (backward span). As well for spatial span task. Four scores are obtained (forward and backward verbal scores, forward and backward visuospatial scores). Performances of each participant are compared to their reference sample.

    Measured: Baseline

  21. Working memory

    Baddeley's dual task assess the ability to coordinate two tasks simultaneously divided attention ability. The score of each participant are compared to their reference sample.

    Measured: Baseline

  22. A sustained attention and working memory test

    PASAT (Paced Auditory Serial Addition Test) is a sustained attention and working memory test. The results are expressed as a score of 60 points. Performances of each participant are compared to their reference sample.

    Measured: Baseline

  23. Language

    The "Dénomination d'Objet 80" (DO 80), is an image naming task in order to assess language and visual gnosias.

    Measured: Baseline

  24. Oculomotor paradigms raw performance - Horizontal saccades Latency

    This concerns saccades Latency (in ms) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

    Measured: Baseline

  25. Oculomotor paradigms raw performance - Horizontal saccades Main velocity

    This concerns saccades Main velocity (in °/sec) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

    Measured: Baseline

  26. Oculomotor paradigms raw performance - Horizontal saccades Gain.

    This concerns saccades Gain (gaze accuracy) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

    Measured: Baseline

  27. Oculomotor paradigms raw performance - Vertical saccades Latency

    This concerns saccades Latency (in ms) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

    Measured: Baseline

  28. Oculomotor paradigms raw performance - Vertical saccades Main Velocity

    This concerns saccades Main velocity (in °/sec) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

    Measured: Baseline

  29. Oculomotor paradigms raw performance - Vertical saccades Gain

    This concerns saccades Gain (gaze accuracy) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

    For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

    Measured: Baseline

  30. Inhibition capacity

    Measure of inhibition capacity performance during an "antisaccades" paradigm. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: percentage of errors. For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

    Measured: Baseline

  31. Internuclear ophthalmoplegia (INO) detection

    Highlight presence/absence of INO. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: INO is present if calculated ratio of abducting to adducting eye movement (both mean and peak velocity) is >1.

    Measured: Baseline

  32. Fixations impairments detection

    Highlight presence/absence of Fixations impairments. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence/frequency of square wave-jerks, nystagmus, flutters.

    Measured: Baseline

  33. Impairment of smooth pursuit

    Highlight Impairment of horizontal and vertical smooth pursuit. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence of saccade and perturbation.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2021
  2. Study start5 Oct 2021
  3. Primary completion5 Aug 2023
  4. Study completion31 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04730167
Sponsor's protocol ID
MIMP
Status last verified
May 2023
First submitted
19 Jan 2021
Last updated
18 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injuries and Concussion, Brain, run by Association de Recherche Bibliographique pour les Neurosciences at 1 site in Monaco.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Monaco. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patients description (time frame: Baseline). The study lists 33 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in